Neurocrine Biosciences (NBIX) Tax Rate (2019 - 2026)

Neurocrine Biosciences (NBIX) posted Tax Rate of 19.81% for Q1 2026, down 44.65% on a QoQ basis from 35.8% in Q4 2025, and down 2644.0% year-over-year from 0.78% in Q1 2025.

Neurocrine Biosciences (NBIX) Tax Rate (2019 - 2026) Analysis & Trends

Neurocrine Biosciences' Tax Rate history runs 8 years deep, the most recent figure standing at 19.81% for Q1 2026.

  • Quarterly Tax Rate fell 2644.0% year-over-year to 19.81% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 28.68% (down 572.0% YoY) and the FY2025 annual result came in at 32.15%, up 238.0% from the prior year.
  • Tax Rate was 19.81% for Q1 2026 at Neurocrine Biosciences, down from 35.8% in the prior quarter.
  • Across five years, Tax Rate topped out at 46.26% in Q1 2025 and bottomed at 25.8% in Q1 2024.
  • A 5-year average of 26.9% and a median of 28.2% in 2025 frame the typical range for Tax Rate.
  • Annual changes were most pronounced in 2024 — Tax Rate slumped 5164 bps — and 2025, when it soared 7206 bps.
  • Neurocrine Biosciences' Tax Rate stood at 24.51% in 2022, then increased by 4 bps to 25.48% in 2023, then jumped by 44 bps to 36.59% in 2024, then fell by 2 bps to 35.8% in 2025, then tumbled by 45 bps to 19.81% in 2026.
  • Business Quant data shows NBIX's Tax Rate at 19.81% in Q1 2026, 35.8% in Q4 2025, and 28.2% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 15.33%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 20.71%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -23.33%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 13.63%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 171.33%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 19.81%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 34.48%
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -435.71%

Historic Data

Download Data
DateValue
Mar 31, 2026 19.81%
Mar 31, 2026 19.81%
Mar 31, 2026 19.81%
Dec 31, 2025 35.80%
Dec 31, 2025 35.80%
Dec 31, 2025 35.80%
Sep 30, 2025 28.20%
Sep 30, 2025 28.20%
Sep 30, 2025 28.20%
Jun 30, 2025 32.60%
Jun 30, 2025 32.60%
Jun 30, 2025 32.60%
Mar 31, 2025 46.26%
Mar 31, 2025 46.26%
Mar 31, 2025 46.26%
Dec 31, 2024 36.59%
Dec 31, 2024 36.59%
Dec 31, 2024 36.59%
Sep 30, 2024 31.79%
Sep 30, 2024 31.79%